Status:
COMPLETED
Open Label, Phase I ZD6474 Head and Neck Cancer Study
Lead Sponsor:
Sanofi
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the maximum tolerated dose of ZD6474 given in combination with radiation or in combination with chemotherapy and radiation in patients with squamous cell carc...
Eligibility Criteria
Inclusion
- Stage III-IV squamous cell carcinoma of the head and neck
Exclusion
- No previous treatment for head and neck cancer, adequate cardiac function
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00450138
Start Date
December 1 2006
End Date
November 1 2011
Last Update
August 29 2016
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Denver, Colorado, United States
2
Research Site
Chicago, Illinois, United States
3
Research Site
Dallas, Texas, United States
4
Research Site
Houston, Texas, United States